These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38643849)

  • 1. Is intrathecal or intraventricular therapy with polymyxins or aminoglycosides still needed to improve the outcome of post-neurosurgical extensively/multidrug-resistant Gram-negative bacteria-related meningitis/ventriculitis in the current era of novel beta-lactams and beta-lactam/beta-lactamase inhibitor combinations?
    Gatti M; Virgili G; Viale P; Pea F
    Int J Antimicrob Agents; 2024 Jun; 63(6):107177. PubMed ID: 38643849
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence.
    Falagas ME; Bliziotis IA; Tam VH
    Int J Antimicrob Agents; 2007 Jan; 29(1):9-25. PubMed ID: 17126534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aminoglycosides and polymyxins].
    Molina J; Cordero E; Palomino J; Pachón J
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens.
    Karaiskos I; Galani I; Souli M; Giamarellou H
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):133-149. PubMed ID: 30626244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review.
    Karaiskos I; Galani L; Baziaka F; Giamarellou H
    Int J Antimicrob Agents; 2013 Jun; 41(6):499-508. PubMed ID: 23507414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases.
    Tängdén T; Enblad P; Ullberg M; Sjölin J
    Clin Infect Dis; 2011 Jun; 52(11):1310-6. PubMed ID: 21540208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer β-Lactam/β-Lactamase inhibitor for multidrug-resistant gram-negative infections: Challenges, implications and surveillance strategy for India.
    Veeraraghavan B; Pragasam AK; Bakthavatchalam YD; Anandan S; Ramasubramanian V; Swaminathan S; Gopalakrishnan R; Soman R; Abraham OC; Ohri VC; Walia K
    Indian J Med Microbiol; 2018; 36(3):334-343. PubMed ID: 30429384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii.
    Chusri S; Sakarunchai I; Kositpantawong N; Panthuwong S; Santimaleeworagun W; Pattharachayakul S; Singkhamanan K; Doi Y
    Int J Antimicrob Agents; 2018 Apr; 51(4):646-650. PubMed ID: 29241820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserving the Dwindling β-lactams-Based Empiric Therapy Options for Gram-Negative Infections in Challenging Resistance Scenario: Lessons Learned and Way Forward.
    Palwe S; Khobragade K; Kharat AS
    Microb Drug Resist; 2020 Jun; 26(6):637-651. PubMed ID: 31851576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant Gram-negative infections: the use of colistin.
    Michalopoulos AS; Karatza DC
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens.
    Bush K
    Int J Antimicrob Agents; 2015 Nov; 46(5):483-93. PubMed ID: 26498989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical intracranial infection due to multidrug-resistant and extensively drug-resistant Gram-negative bacteria: A systematic review and meta-analysis.
    Hu Y; He W; Yao D; Dai H
    Int J Antimicrob Agents; 2019 Nov; 54(5):556-561. PubMed ID: 31398478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state.
    Remeš F; Tomáš R; Jindrák V; Vaniš V; Setlík M
    J Neurosurg; 2013 Dec; 119(6):1596-602. PubMed ID: 23952688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular antibiotics for bacterial meningitis in neonates.
    Shah SS; Ohlsson A; Shah VS
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD004496. PubMed ID: 22786491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of newer β lactams/ β lactamase inhibitors for treatment of multidrug resistant gram negative infections in burn patients.
    Gupta K; Dash S
    Burns; 2019 Nov; 45(7):1725-1726. PubMed ID: 31445712
    [No Abstract]   [Full Text] [Related]  

  • 17. Will new antimicrobials overcome resistance among Gram-negatives?
    Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.
    Karakonstantis S; Kritsotakis EI; Gikas A
    Infection; 2020 Dec; 48(6):835-851. PubMed ID: 32875545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of new β-lactamase inhibitors in gram-negative infections.
    Vena A; Castaldo N; Bassetti M
    Curr Opin Infect Dis; 2019 Dec; 32(6):638-646. PubMed ID: 31577557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.